TRCN0000338399 Citations (1)
Originally described in: Integrated genetic and pharmacologic interrogation of rare cancers.Hong AL, Tseng YY, Cowley GS, Jonas O, Cheah JH, Kynnap BD, Doshi MB, Oh C, Meyer SC, Church AJ, Gill S, Bielski CM, Keskula P, Imamovic A, Howell S, Kryukov GV, Clemons PA, Tsherniak A, Vazquez F, Crompton BD, Shamji AF, Rodriguez-Galindo C, Janeway KA, Roberts CW, Stegmaier K, van Hummelen P, Cima MJ, Langer RS, Garraway LA, Schreiber SL, Root DE, Hahn WC, Boehm JS Nat Commun. 2016 Jun 22;7:11987. doi: 10.1038/ncomms11987. PubMed Journal
Articles Citing TRCN0000338399
| Articles |
|---|
| Molecular profiling of anastatic cancer cells: potential role of the nuclear export pathway. Seervi M, Sumi S, Chandrasekharan A, Sharma AK, SanthoshKumar TR. Cell Oncol (Dordr). 2019 May 30. pii: 10.1007/s13402-019-00451-1. doi: 10.1007/s13402-019-00451-1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.